The Chemours Company CC
$14.58
-$0.45-2.99%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -304.00M | -410.00M | -386.00M | -337.00M | -429.00M |
| Total Depreciation and Amortization | 342.00M | 354.00M | 363.00M | 333.00M | 327.00M |
| Total Amortization of Deferred Charges | 10.00M | 11.00M | 11.00M | 12.00M | 12.00M |
| Total Other Non-Cash Items | -22.00M | 79.00M | 111.00M | 120.00M | 180.00M |
| Change in Net Operating Assets | 371.00M | 298.00M | 165.00M | 137.00M | 168.00M |
| Cash from Operations | 397.00M | 332.00M | 264.00M | 265.00M | 258.00M |
| Capital Expenditure | -179.00M | -178.00M | -213.00M | -277.00M | -312.00M |
| Sale of Property, Plant, and Equipment | 13.00M | 14.00M | 7.00M | 7.00M | 1.00M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 283.00M | 0.00 | 0.00 | 0.00 | 1.00M |
| Cash from Investing | 117.00M | -164.00M | -206.00M | -270.00M | -310.00M |
| Total Debt Issued | 1.42B | 1.52B | 828.00M | 791.00M | 794.00M |
| Total Debt Repaid | -1.72B | -1.55B | -889.00M | -703.00M | -703.00M |
| Issuance of Common Stock | 3.00M | 2.00M | -- | 1.00M | 1.00M |
| Repurchase of Common Stock | -2.00M | -2.00M | -1.00M | -1.00M | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -54.00M | -54.00M | -78.00M | -99.00M | -124.00M |
| Other Financing Activities | 2.00M | -2.00M | 14.00M | 7.00M | 7.00M |
| Cash from Financing | -350.00M | -88.00M | -126.00M | -4.00M | -26.00M |
| Foreign Exchange rate Adjustments | 6.00M | 21.00M | 29.00M | 8.00M | 12.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 170.00M | 101.00M | -39.00M | -1.00M | -66.00M |